• Find people
• Intranet

Musculoskeletal Research Xavier Nogués

Publications 2024 (16)

• Planella-Fontanillas N^*, Rial A, Villar-García J, Parra-Navarro L, Santiago P, Pujol RM, Rodríguez-Morera J. Hepatic inflammatory pseudotumours mimicking metastatic disease in a non-HIV patient with secondary syphilis. J Eur Acad Dermatol Venereol 2024: (en Premsa).
• Cosman F^*, Lewiecki EM, Eastell R, Ebeling PR, De Beur SJ, Langdahl B, Rhee Y, Fuleihan GE, Kiel DP, Schousboe JT, Borges JL, Cheung AM, Díez-Pérez A, Hadji P, Tanaka S, Thomasius F, Xia W, Cummings SR. Goal-Directed Osteoporosis Treatment: ASBMR/BHOF Task Force Position Statement 2024. J Bone Miner Res 2024: (en Premsa).
• Sharma M^*, Beaudart C, Clark P, Fujiwara S, Adachi JD, Papaioannou A, Messina OD, Morin SN, Kohlmeier L, Nogués X, Leckie C, Harvey NC, Kanis JA, Reginster JY, Hiligsmann M, Silverman SL. Clinical and demographic factors determining patient fracture risk decision point (FRDP): The improving risk communication in osteoporosis (RICO) project. Osteoporosis Int 2024: (en Premsa).
• Sabariego-Puigvila B, Muñoz-Bermúdez R, Palomino A, Navarro P, Pallàs-Villaronga O, Supervía A^*. Predictors of poor outcome in intoxicated patients treated in an emergency department. Emergencias 2024; 36(5): 395-398.
• Veronese N^*, Briot K, Guañabens N, Albergaria BH, Alokail M, Al-Daghri N, Bemden AB, Bruyère O, Burlet N, Cooper C, Curtis EM, Ebeling PR, Halbout P, Hesse E, Hiligsmann M, Camargos BM, Harvey NC, Díez-Pérez A, Radermecker RP, Reginster JY, Rizzoli R, Siggelkow H, Cortet B, Brandi ML. Recommendations for the optimal use of bone forming agents in osteoporosis. Aging Clin Exp Res . 2024; 36(1): 167.
• García-Giralt N^*, Ovejero D, Grinberg D, Nogués X, Castañeda S, Balcells S, Rabionet R. Assessing the contribution of genes involved in monogenic bone disorders to the etiology of atypical femoral fractures. Hum Genomics 2024; 18(1): 87.
• Pineda-Torcuato A, Caballero-Bermejo AF, Rodríguez-Miranda B, Supervía A, Puiguriguer-Ferrando J, Ruiz-Antorán B, SILITOX study-group. Adherence to the Extracorporeal Treatments in Poisoning Workgroup recommendations for lithium intoxication: the SILITOX study. Emergencias 2024; 36(3): 235-236.
• Supervía A, Caballero-Bermejo AF^*, Puiguriguer J, Córdoba F, Martínez-Baladrón A, Callado F, Lobo-Antuña V, Fuentes E, Molina-Samper V, Vert S, Ruíz-Ruíz F, Guijarro-Eguinoa FJ, Martín-Pérez B, Olmos S, Ruiz-Antorán B, Maza-Vera MT, Pallàs-Villaronga O, Climent B, Igartua-Astibia M, Gutiérrez E, Nogué S, Ferrer-Dufol A, Burillo Putze G. Seven- and thirty-day mortality in digoxin poisoning: Results from the DIGITOX study. Am J Emerg Med 2024; 81: 92-98.
• Fuggle NR, Reginster JY, Al-Daghri N, Bruyère O, Burlet N, Campusano C, Cooper C, Díez-Pérez A, Halbout P, Ghi T, Kaufman JM, Kurt A, Matijevic R, Radermecker RP, Tuzun S, Veronese N, Rizzoli R, Harvey NC, Brandi ML, Brandi ML. Radiofrequency echographic multi spectrometry (REMS) in the diagnosis and management of osteoporosis: state of the art. Aging Clin Exp Res . 2024; 36(1): 135.
• Roca-Ayats N, Maceda I, Bruque CD, Martínez-Gil N, García-Giralt N, Cozar M, Mellibovsky L, Van Hul W, Lao O^*, Grinberg D, Balcells S. Evolutionary and functional analyses of LRP5 in archaic and extant modern humans. Hum Genomics 2024; 18(1): 53.
• Marín-Casino M^*, Clemente-Rodríguez C, Supervía A. Changes in intoxications during the warning period by the COVID-19 pandemic. Med Clin (Barc) 2024; 162(7): 354-355.
• Vandenput L, Johansson H, McCloskey EV, Liu E, Schini M, Åkesson KE, Anderson FA, Azagra R, Bager CL, Beaudart C, Bischoff-Ferrari HA, Biver E, Bruyère O, Cauley JA, Center JR, Chapurlat R, Christiansen C, Cooper C, Crandall CJ, Cummings SR, da Silva JAP, Dawson-Hughes B, Díez-Pérez A, Dufour AB, Eisman JA, Elders PJM, Ferrari S, Fujita Y, Fujiwara S, Glüer CC, Goldshtein I, Goltzman D, Gudnason V, Hall J, Hans D, Hoff M, Hollick RJ, Huisman M, IKI M, Ish-Shalom S, Jones G, Karlsson MK, Khosla S, Kiel DP, Koh WP, Koromani F, Kotowicz MA, Kröger H, Kwok T, Lamy O, Langhammer A, Larijani B, Lippuner K, McGuigan FEA, Mellström D, Merlijn T, Nguyen TV, Nordström A, Nordström P, O'Neill TW, Obermayer-Pietsch B, Ohlsson C, Orwoll ES, Pasco JA, Rivadeneira F, Schott AM, Shiroma EJ, Siggeirsdottir K, Simonsick EM, Sornay-Rendu E, Sund R, Swart KMA, Szulc P, Tamaki J, Torgerson DJ, van Schoor NM, van Staa TP, Vila J, Wareham NJ, Wright NC, Yoshimura N, Zillikens M, Zwart M, Harvey NC, Lorentzon M, Leslie WD, Kanis JA^*. A meta-analysis of previous falls and subsequent fracture risk in cohort studies. Osteoporosis Int 2024; 35(3): 469-494.
• Rufus-Membere P^*, Anderson KB, Holloway-Kew KL, Harland JW, Díez-Pérez A, Kotowicz MA, Pasco JA. The practicality of using bone impact microindentation in a population-based study of women: A Geelong-Osteoporosis Study. Bone Rep 2024; 20: 101733 (Acceptat).
• Beaudart C^*, Sharma M, Clark P, Fujiwara S, Adachi JD, Messina OD, Morin SN, Kohlmeier LA, Sangan CB, Nogués X, Cruz-Priego GA, Cavallo A, Cooper F, Grier J, Leckie C, Montiel-Ojeda D, Papaioannou A, Raskin N, Yurquina L, Wall M, Bruyère O, Boonen A, Dennison E, Harvey NC, Kanis JA, Kaux JF, Lewiecki EM, Lopez-Borbon O, Paskins Z, Reginster JY, Silverman S, Hiligsmann M. Patients' preferences for fracture risk communication: the Risk Communication in Osteoporosis (RICO) study. Osteoporosis Int 2024; 35(3): 451-468.
• Camps-Vilaró A, Pinsach-Abuin ML, Dégano IR, Ramos R, Martí-Lluch R, Elosua R, Subirana I, Solà C, Puigmulé M, Perez A, Vilaró I, Cruz R, Diz-de Almeida S, Nogués X, Masclans JR, Güerri R, Marin J, Tizon H, Vaquerizo B, Brugada R, Marrugat J^*. Genetic characteristics involved in COVID-19 severity. The CARGENCORS case-control study and meta-analysis. J Med Virol 2024; 96(2): e29404.
• Sisteré-Oró M, Du J, Wortmann DDJ, Filippi MD, Cañas-Ruano E, Arrieta I, Marcos A, Castells X, Grau S, García-Giralt N, Perez-Zsolt D, Boreika R, Izquierdo-Useros N, Güerri R^*, Meyerhans A^*. Pan-pox-specific T-cell responses in HIV-1-infected individuals after JYNNEOS vaccination. J Med Virol 2024; 96(1): e29317.